NASDAQ: NVCR       Novocure Ltd Ord Sh
Last Price Today's Change   Day's Range   Trading Volume
79.52   +4.62 (6.17%)  73.24 - 79.62  1,222,700


Avg Volume (4 weeks):789,426
4 Weeks Range:67.44 - 83.60
4 Weeks Price Volatility (%):
52 Weeks Range:56.05 - 120.03
52 Weeks Price Volatility (%):
Average Price Target:-


No recent Headlines for this stock.

Business Background

NovoCure Ltd serves in the healthcare sector of United States. Its business involves commercial stage oncology operations involving therapies to cure critical tumors. Its key offering is the TTFields therapy, which is a low-toxicity anti-mitotic treatment that uses low-intensity, intermediate frequency, alternating electric fields to exert physical forces on molecules inside cancer cells, thereby leading to cancer cell death. NovoCure derives its major revenues in the United States, through the sale of TTFields delivery system, which includes a portable electric field generator, transducer arrays, rechargeable batteries, and accessories.

  Be the first to like this.

I3 Messenger
Individual or Group chat with anyone on I3investor

6687  2946  917  902 

Top 10 Active Counters
 TSLA 213.97+6.45 
 SQQQ 21.74-0.48 
 TQQQ 36.82+0.81 
 T 15.21-0.60 
 UTRS 0.293+0.093 
 MMV 2.04+1.09 
 SPY 427.92+6.10 
 YJ 0.32+0.108 
 PLTR 14.52-0.02 
 BAC 28.71+0.93